Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
1.47
Open
1.45
Day Range1.45 – 1.48
1.45
1.48
52W Range0.58 – 2.50
0.58
2.50
46% of range
50-Day MA
1.56(-6.5%)
200-Day MA
1.22(+19.8%)
VOLUME & SIZE
Avg Volume
2.5M
FUNDAMENTALS
P/E Ratio
-0.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.45
Market-like
TECHNICAL
RSI (14)
42
Bearish momentum
INM News
About
inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.